Published in Prog Clin Biol Res on January 01, 1987
Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med (1999) 11.19
Effectiveness of St John's wort in major depression: a randomized controlled trial. JAMA (2001) 5.37
Cimetidine: interaction with oral anticoagulants in man. Lancet (1979) 4.67
Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens. J Exp Med (1978) 4.51
Depressed maternal lymphocyte response to phytohaemagglutinin in human pregnancy. Lancet (1972) 4.47
Three closely linked genetic systems relevant to transplantation. Proc Natl Acad Sci U S A (1971) 4.14
Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology (2003) 3.82
Bioethics for clinicians: 1. Consent. CMAJ (1996) 3.60
IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest (2000) 3.19
Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med (1989) 2.77
Skin metastases in cancer patients. Cutis (1987) 2.76
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci U S A (2001) 2.61
The effects of oxytocin and vasopressin on partner preferences in male and female prairie voles (Microtus ochrogaster). Behav Neurosci (1999) 2.48
Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science (1987) 2.48
Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen (2000) 2.47
Influence of diet on survival of mice. Proc Natl Acad Sci U S A (1976) 2.45
Deficient immunologic functions of NZB mice. Proc Soc Exp Biol Med (1968) 2.41
Ultrastructural studies of the dying-back process. II. The sequestration and removal by Schwann cells and oligodendrocytes of organelles from normal and diseases axons. J Neurocytol (1974) 2.27
Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man. Proc Natl Acad Sci U S A (1983) 2.23
A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol (2007) 2.21
Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol (1997) 2.15
Detection of neuroblastoma in the bone marrow: biopsy versus aspiration. J Pediatr Hematol Oncol (1998) 2.06
Lymphocyte phytohemagglutinin responsiveness, immunoglobulins and autoantibodies in aging humans. J Immunol (1973) 2.04
The histocompatibility system in juvenile, insulin-dependent diabetic multiplex kindreds. J Clin Invest (1977) 2.01
Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. J Clin Invest (1986) 2.00
Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac? Acta Psychiatr Scand (2007) 1.94
Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man. Hum Immunol (1981) 1.94
Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication. J Neuropathol Exp Neurol (1974) 1.86
Degeneration in central and peripheral nervous systems produced by pure n-hexane: an experimental study. Brain (1976) 1.84
Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration. J Neuropathol Exp Neurol (1977) 1.80
Galactorrhea induced by sertraline. Am J Psychiatry (1993) 1.75
The examination of isolated nerve fibres by light and electron microscopy, with observations on demyelination proximal to neuromas. Acta Neuropathol (1970) 1.70
Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies. J Neuropathol Exp Neurol (1977) 1.69
Autoimmune phenomena and renal disease in mice. Role of thymectomy, aging, and involution of immunologic capacity. Lab Invest (1970) 1.69
Nervous system degeneration produced by the industrial solvent methyl n-butyl ketone. Arch Neurol (1975) 1.66
Suppressor lymphocytes in young and aged humans. J Immunol (1977) 1.66
Fast neutron therapy for squamous cell carcinoma in the head and neck region: results of a randomized trial. Int J Radiat Oncol Biol Phys (1987) 1.65
The dopamine hypothesis of schizophrenia: a review. Schizophr Bull (1976) 1.65
Precision cutting and patterning of graphene with helium ions. Nanotechnology (2009) 1.64
Antinociceptive activitiy of narcotic agonist and partial agonist analgesics and other agents in the tail-immersion test in mice and rats. Neuropharmacology (1976) 1.61
Interobserver and intraobserver variation in classification systems for fractures of the distal humerus. J Bone Joint Surg Br (2000) 1.60
Extended major histocompatibility complex haplotypes in type I diabetes mellitus. J Clin Invest (1984) 1.58
Association of an HLA-DQ allele with clinical tuberculosis. JAMA (1998) 1.58
Familial rheumatoid arthritis: a kindred identified through a proband with seronegative juvenile arthritis includes members with seropositive, adult-onset disease. Hum Immunol (1982) 1.57
Clinical and epidemiologic characteristics of nodding syndrome in Mundri County, southern Sudan. Afr Health Sci (2012) 1.56
The fate of Schwann cells isolated from axonal contact. J Neurocytol (1978) 1.54
Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit Rev Toxicol (2007) 1.54
Influence of dietary restriction on immunologic function and renal disease in (NZB x NZW) F1 mice. Proc Natl Acad Sci U S A (1978) 1.52
Antigen-specific helper factor in man. J Exp Med (1978) 1.51
Environmental antecedents of young-onset Parkinson's disease. Neurology (1993) 1.49
Studies on the control of myelinogenesis. II. Evidence for neuronal regulation of myelin production. Brain Res (1976) 1.49
Association of HL-A 5 and immune responsiveness in vitro to streptococcal antigens. J Exp Med (1975) 1.48
The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program. Diabetes Care (1993) 1.47
Occurrence of lymphocytes within the gut epithelium of normal and neonatally thymectomized mice. Proc Soc Exp Biol Med (1968) 1.47
HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia. Arch Gen Psychiatry (1990) 1.46
Inherited deficiency of the second component of complement (C2) with membranoproliferative glomerulonephritis. Am J Med (1977) 1.46
Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens (1998) 1.46
No requirement for V(D)J recombination in p53-deficient thymic lymphoma. Mol Cell Biol (1998) 1.45
Dietary restrictions early and late: effects on the nephropathy of the NZB X NZW mouse. Lab Invest (1978) 1.45
Monoclonal antibody identifies a new Ia-like (p29,34) polymorphic system linked to the HLA-D/DR region. Nature (1981) 1.45
Acute lymphoblastic leukemic cells with T (thymus-derived) lymphocyte markers. Science (1973) 1.45
Continuous cataplexy in a patient with a midbrain tumor: the limp man syndrome. Neurology (1980) 1.44
Postthymectomy wasting associated with autoimmune phenomena. I. Antiglobulin-positive anemia in A and C57BL-6 Ks mice. J Exp Med (1967) 1.44
Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes. Immunogenetics (1984) 1.43
Dynamics of reactive oxygen intermediate production in human glioma: n-6 essential fatty acid effects. Eur J Clin Invest (1999) 1.42
Prenatal screening for open neural-tube defects in Maine. N Engl J Med (1999) 1.42
The metabolic syndrome and schizophrenia. Acta Psychiatr Scand (2009) 1.40
The neuroectodermal tumor of bone. Am J Surg Pathol (1984) 1.39
Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci U S A (1990) 1.39
Immunopathology of aging. Hum Pathol (1974) 1.39
Inclusion body myositis. Lab Invest (1971) 1.39
Pulmonary nodules: effect on detection of spiral CT pitch. Radiology (1996) 1.38
Tracheal mucus flow rates in experimental bronchitis in rats. Br J Exp Pathol (1969) 1.38
Studies on thymus function. I. Cooperative effect of thymic function and lymphohemopoietic cells in restoration of neonatally thymectomized mice. J Exp Med (1970) 1.38
The enlarging view of hexacarbon neurotoxicity. Crit Rev Toxicol (1980) 1.36
Tropism in nerve regeneration in vivo. Attraction of regenerating axons by diffusible factors derived from cells in distal nerve stumps of transected peripheral nerves. Brain Res (1982) 1.36
Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol (2005) 1.36
Thymus: an essential factor in lymphoid repopulation. Transplant Proc (1969) 1.36
Influence of protein restriction on immune functions in NZB mice. J Immunol (1976) 1.36
Canadian physicians and euthanasia: 2. Definitions and distinctions. CMAJ (1993) 1.35
Nerve compression lesions of the upper extremity. A clinical and experimental review. Clin Orthop Relat Res (1974) 1.35
Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays. J Clin Invest (1978) 1.35
3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can J Neurol Sci (1991) 1.30
Does a defect of energy metabolism in the nerve fiber underlie axonal degeneration in polyneuropathies? Ann Neurol (1979) 1.29
A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathologic mechanisms. Can J Neurol Sci (1974) 1.29
Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med (1986) 1.29
Cubital tunnel external compression syndrome. Br Med J (1973) 1.28
A family with hereditary ataxia: HLA typing. Neurology (1980) 1.28
Progressive loss in vitro of cellular immunity with ageing in strains of mice susceptible to autoimmune disease. Clin Exp Immunol (1971) 1.28
Studies on thymus function. II. Cooperative effect of newborn and embryonic hemopoietic liver cells with thymus function. J Exp Med (1970) 1.27
Prognostic factors in osteosarcoma. A review of 20 year's experience at the University of Pittsburgh Health Center Hospitals. Cancer (1975) 1.27
Effects of centrally acting drugs on exploratory behaviour in rats. Br J Pharmacol Chemother (1965) 1.26
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. II. General pathologic, neuropathologic, and biochemical aspects. Neurology (1977) 1.26
Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design. Hum Immunol (2001) 1.25
Traits that influence longevity in mice. Genetics (1984) 1.25
An audit of the effect of a 24-hour emergency operating theatre in a district general hospital. Ann R Coll Surg Engl (1994) 1.25
Demonstration of respiratory syncytial virus in an autopsy series. Pediatr Pathol (1990) 1.24
Carcinogen-induced tumors of the thymus. IV. Humoral influences of normal thymus and functional thymomas and influence of posthymectomy period on restoration. J Exp Med (1969) 1.24
Environmental hydrocarbons produce degeneration in cat hypothalamus and optic tract. Science (1978) 1.24
Human C4 haplotypes with duplicated C4A or C4B. Am J Hum Genet (1984) 1.24